Jaksil, Jalil .

HRN: 22-40-45  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/31/2022
CEFUROXIME 750MG (VIAL)
12/31/2022
01/06/2023
IVT
750mg
Q8hrs
Uti
Waiting Final Action 
12/31/2022
CEFTRIAXONE 1G (VIAL)
12/31/2022
01/06/2023
IVT
2g
OD
Typhoid Fever
Waiting Final Action 
01/04/2023
AZITHROMYCIN 500MG TABLET (TAB)
01/04/2023
01/11/2023
ORAL
500mg
OD
UTI; Typhoid Fever
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: